Unichem Laboratories share price
You have to be logged in to add this to Watchlist.- ₹450.20(0.47%)June 17, 2026 15:58:41 PM IST
- NSE
- BSE
- Vol : 412.80 K (NSE + BSE)Last 20 day avg : 1.75 M
Unichem Laboratories is trading 0.47% upper at Rs 450.20 as compared to its last closing price. Unichem Laboratories has been trading in the price range of 466.75 & 437.50. Unichem Laboratories has given 1.02% in this year & 17.57% in the last 5 days. Unichem Laboratories has TTM P/E ratio 8.17 as compared to the sector P/E of 26.87.The company posted a net profit of 10.91 Crores in its last quarter.Listed peers of Unichem Laboratories include Themis Medicare (1.82%), Pfizer (0.05%), Jagsonpal Pharmaceuticals (-0.12%).The Mutual Fund holding in Unichem Laboratories was at 9.07% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Unichem Laboratories was at 1.00% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jun 17, 2026, 02:21 PM UTC
- BetaMedium volatility0.91Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.18The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.25The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Themis Medicare | Neutral | 103.50 | 1.82 | 963.67 | 31.81 | 2.35 | 0.49 | 4.62 |
| Pfizer | Bearish | 4,504.45 | 0.05 | 20,549.10 | 36.12 | 5.46 | 0.69 | 1.60 |
| Jagsonpal Pharmaceuticals | Bullish | 208.55 | -0.12 | 1,401.87 | 33.88 | 5.54 | 1.25 | 3.18 |
| Aurobindo Pharma | Neutral | 1,422.20 | 1.94 | 82,309.56 | 20.15 | 2.15 | 0.33 | 5.52 |
| Neuland Laboratories | Bullish | 16,981.45 | 1.60 | 21,738.69 | 92.96 | 12.69 | 0.08 | 7.17 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-22 | Audited Results |
| 2026-02-05 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-22 | Audited Results |
- IndustryMajor Drugs
- ISININE351A01035
- BSE Code506690
- NSE CodeUNICHEMLAB
Unichem Laboratories is trading at 450.20 as on Wed Jun 17 2026 10:28:41. This is 0.47% upper as compared to its previous closing price of 448.10.
The market capitalization of Unichem Laboratories is 3213.41 Cr as on Wed Jun 17 2026 10:28:41.
The 52 wk high for Unichem Laboratories is 656.85 whereas the 52 wk low is 280.00
Unichem Laboratories can be analyzed on the following key metrics -
- TTM P/E: 8.17
- Sector P/E: 26.87
- Dividend Yield: 0.00%
- D/E ratio: 0.18
Unichem Laboratories reported a net profit of 252.84 Cr in 2026.
The Mutual Fund Shareholding was 9.07% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Unichem Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.